An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies.

Trial Profile

An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2009

At a glance

  • Drugs Patupilone (Primary) ; Warfarin
  • Indications Cancer
  • Focus Pharmacokinetics
  • Sponsors Novartis; Novartis Pharmaceuticals
  • Most Recent Events

    • 02 Jun 2009 Actual number of patients (17) added as reported by ClinicalTrials.gov.
    • 02 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top